Connecticut 2022 Regular Session

Connecticut House Bill HB05042

Introduced
2/10/22  
Introduced
2/10/22  
Refer
2/10/22  
Report Pass
3/10/22  
Report Pass
3/10/22  
Refer
3/15/22  
Report Pass
3/22/22  
Report Pass
3/22/22  
Engrossed
4/27/22  
Engrossed
4/27/22  

Caption

An Act Concerning Health Care Cost Growth.

Impact

The passing of HB 5042 is set to amend current statutes related to health care management within the state. By providing a formal structure for state oversight of health care costs and quality, the bill could lead to significant changes in how health care is delivered and financed. It also empowers the executive director of the new office to enforce compliance with established benchmarks and publicly report on the performance of different health care entities, making the data more transparent and accessible to consumers and stakeholders.

Summary

House Bill 5042, also known as the Act Concerning Health Care Cost Growth, establishes comprehensive strategies to manage and reduce health care costs in the state. It creates the Office of Health Strategy, which will be tasked with implementing a cohesive health care vision, developing cost containment strategies, ensuring quality of care, and promoting accessibility for all state residents. This includes setting annual health care cost growth benchmarks and primary care spending targets aimed at improving financial stability within the health care system.

Sentiment

The general sentiment around HB 5042 appears to be positive among proponents who argue that it will address the escalating costs associated with health care and improve overall quality through regulated benchmarks. Supporters highlight the importance of creating a systematic approach to health care that enhances transparency and accountability. However, there are also concerns from critics who fear that regulating costs might limit the ability of health care providers to operate flexibly and could stifle innovation in patient care.

Contention

Notable points of contention surrounding HB 5042 include discussions over the effectiveness of the proposed benchmarks and transparency measures. Critics argue that while the intent of lowering costs and improving quality is admirable, the actual implementation of these strategies may lead to unintended consequences. For instance, there are apprehensions that strict adherence to cost growth benchmarks could create a one-size-fits-all approach, potentially compromising the quality of care for specific populations or communities.

Companion Bills

No companion bills found.

Similar Bills

CT SB01116

An Act Concerning A State-operated Reinsurance Program And Health Care Cost Growth.

CT SB00210

An Act Concerning A State-operated Reinsurance Program, Health Care Cost Growth And Site Of Service Billing Requirements.

CT HB05018

An Act Concerning Health Care Cost Growth In Connecticut.

CT SB00328

An Act Concerning Health Care Cost Growth Benchmarks, Canadian Drug Reimportation, Stop-loss Insurance And Reinsurance.

CT SB00844

An Act Concerning The Insurance Department's Recommendations Regarding Value-added Products And Services And Prohibited Insurance Practices.

CT HB06687

An Act Concerning Medical Assistance For Children And Adults Without Health Care Coverage.

CT SB01006

An Act Concerning Health Care Costs, The Connecticut Health Insurance Exchange And Health Equity.

CT HB05054

An Act Addressing Health Care Affordability.